TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $782,000 | -1.3% | 47,760 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $792,000 | -11.4% | 48,025 | -1.9% | 0.00% | 0.0% |
| Q1 2021 | $894,000 | -6.6% | 48,956 | -6.9% | 0.00% | 0.0% |
| Q4 2020 | $957,000 | +6.1% | 52,572 | +4.0% | 0.00% | 0.0% |
| Q3 2020 | $902,000 | -92.2% | 50,571 | -92.2% | 0.00% | -94.1% |
| Q2 2020 | $11,611,000 | +8.7% | 647,564 | -8.0% | 0.02% | -5.6% |
| Q1 2020 | $10,684,000 | -25.6% | 703,852 | -3.3% | 0.02% | -14.3% |
| Q4 2019 | $14,363,000 | +29.1% | 727,975 | +12.5% | 0.02% | +23.5% |
| Q3 2019 | $11,129,000 | +18.4% | 647,025 | +21.8% | 0.02% | +21.4% |
| Q2 2019 | $9,400,000 | -22.8% | 531,093 | -11.1% | 0.01% | -26.3% |
| Q1 2019 | $12,173,000 | +271.8% | 597,600 | +370.9% | 0.02% | +216.7% |
| Q4 2018 | $3,274,000 | – | 126,895 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |